Task force 3: Recipient guidelines/prioritization

Journal of the American College of Cardiology

Volumn 22, Issue 1, 1993, Pages 21-31

  Mudge, Gilbert H ^a   Goldstein, Sidney ^a   Addonizio, Linda J ^a   Caplan, Arthur ^a   Mancini, Donna ^a   Levine, T Barry ^a   Ritsch Jr , Malcolm E ^a   Stevenson, Lynne Warner ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HEART TRANSPLANTATION; HUMAN; PEDIATRIC SURGERY; PRIORITY JOURNAL; RECIPIENT; ADULT; ARTICLE; CHILD; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; STANDARD; UNITED STATES;

ADULT; CHILD; HEART TRANSPLANTATION; HUMAN; ORGAN PROCUREMENT; UNITED STATES;

EID: 0027310721     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(93)90812-F     Document Type: Article

References (57)

1. Effects of enalapril on mortality in severe congestive heart failure Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
2. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity
3. The registry of the International Society of Heart Transplantation: Seventh Official Report—1990
4. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
5. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
6. 5th Bethesda Conference Report Cardiac and Other Organ Transplantation
7. The potential contribution of cardiac replacement to the control of cardiovascular diseases: a population based estimate
8. Executive summary: The National Cooperative Transplantation Study
9. Social, economic, and insurance issues in cardiac replacement
10. The potential supply of organ donors: an assessment of organ procurement effects in the United States
11. Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of multicenter survey
12. Results of heart transplantation for active lymphocytic myocarditis
13. Substance abuser does this warrant exclusion for transplant (abstr)
14. Cardiac allograft survival in “reformed” substance abusers (abstr)
15. Long-term results in diabetic patients undergoing cardiac transplantation
16. Cardiac transplantation for intractable prosthetic valve endocarditis
17. Simultaneous heart and kidney transplantation: a report of three cases and review of the literature
18. Heart transplantation in elderly patients
19. Determinants of operative risk in human heart transplantation
20. Utility of preoperative right heart catheterization data as a predictor of survival after heart transplantation (abstr)
21. Heterotopic heart transplantation: current status in 1988
22. Cardiac transplantation in the pediatric patient
23. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group
24. Utility of prostaglandin E-1 in the pretransplant evaluation of cardiac failure patients with significant pulmonary hypertension
25. Psychiatric aspects of heart transplantation: preoperative evaluation and postoperative sequelae
26. Cardiac transplantation: clinical correlates of psychiatric outcome
27. The PACT: a rating scale for the study of clinical decision-making in psychosocial screening of organ transplant candidates
28. Psychological evaluation of heart transplantation candidates: an international survey of process, criteria, and outcomes
29. Psychosocial profile of noncompliant patients
30. Noncompliance in organ transplant recipients
31. The Registry of the International Society for Heart and Lung Transplantation. Ninth Official Report
32. Outcomes of infants and children with dilated cardiomyopathy
33. Cardiac transplantation for cardiomyopathies of childhood
34. Pediatric heart transplantation following surgery involving the pulmonary arteries
35. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics
36. Cardiac transplantation as therapy for heart failure
37. Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation
38. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens
39. Distribution of donor hearts to maximize transplant candidate survival
40. Exercise capacity for survivors of cardiac transplantation or sustained, medical therapy for stable heart failure
41. Normalization of oxygen deficit in low-level exercise may explain major functional improvements after cardiac transplantation (abstr)
42. Predictors of total mortality and sudden death in mild to moderate heart failure
43. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate
44. Survival in men with severe chronic left ventricular failure due to either coronary artery disease or idiopathic dilated cardiomyopathy
45. Factors influencing the one-year mortality of dilated cardiomyopathy
46. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
47. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe heart failure
48. Antiarrhythmic drug use and high serum levels of digoxin are independent adverse prognostic factors in patients with chronic heart failure
49. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation
50. Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤20% secondary to ischemic or non-ischemic dilated cardiomyopathy
51. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure
52. Importance of serial exercise testing after evaluation for cardiac transplantation
53. Prognostic value of an abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy